(Q37186967)

18 August 2017

Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer (English)

1 reference

18 August 2017

1

Wassim Kassouf

1 reference

18 August 2017

2

Peter C Black

1 reference

18 August 2017

Tomasz Tuziak

3

1 reference

18 August 2017

Jolanta Bondaruk

4

1 reference

18 August 2017

Sangkyou Lee

5

1 reference

18 August 2017

Gordon A Brown

6

1 reference

18 August 2017

Liana Adam

7

1 reference

18 August 2017

Caimiao Wei

8

1 reference

18 August 2017

Keith Baggerly

9

1 reference

18 August 2017

Menashe Bar-Eli

10

1 reference

18 August 2017

David McConkey

11

1 reference

18 August 2017

Bogdan Czerniak

12

1 reference

18 August 2017

Colin P Dinney

13

1 reference

18 August 2017

language of work or name

English

0 references

publication date

19 November 2007

1 reference

18 August 2017

1 reference

18 August 2017

179

1 reference

18 August 2017

1

1 reference

18 August 2017

353-358

1 reference

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Prognostic value of ERBB family mRNA expression in breast carcinomas

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680144

Long-term outcome related to epidermal growth factor receptor status in bladder cancer

3 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

Epidermal growth factor receptor expression: predictive value for the outcome after cystectomy for bladder cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

Amplification/overexpression of a mitotic kinase gene in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18006009

12 December 2020

10.1016/J.JURO.2007.08.087

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18006009

1 reference